Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
暂无分享,去创建一个
P. Hellström | L. Kupčinskas | F. Nagy | Z. Tulassay | J. Bohr | G. Bouma | M. Pierik | M. Krauss | G. Lindberg | A. Lucendo | A. Dignass | S. Miehlke | R. Greinwald | W. Kruis | J. Kupcinskas | F. Fernández-Bañares | L. Vigren | L. Munck | F. Zsigmond | T. Rannem | M. Bläker | E. Mihály | A. Münch | A. Madisch | O. Bonderup | T. Nacak | E. Meier | G. Böhm | C. Kirsch | K. Rehbehn | D. Aust | P. Armerding | Jiri Stehlk | G. Böhm | M. Hoesl | G. Kiss | B. Lebrun | Miroslav Wielondek | Stephan Miehlke | Ole Bonderup | Stephan Miehlke | J. Kupčinskas
[1] Anastasios Koulaouzidis,et al. Endoscopic findings and colonic perforation in microscopic colitis: A systematic review. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[2] A. Ford,et al. Macroscopic findings, incidence and characteristics of microscopic colitis in a large cohort of patients from the United Kingdom , 2017, Scandinavian journal of gastroenterology.
[3] A. Duhamel,et al. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study , 2017, Digestive Diseases and Sciences.
[4] AGA Institute Guideline on the Management of Microscopic Colitis: Clinical Decision Support Tool. , 2016, Gastroenterology.
[5] S. Vege,et al. American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis. , 2016, Gastroenterology.
[6] S. Bonovas,et al. Systematic review with network meta‐analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease , 2015, Alimentary pharmacology & therapeutics.
[7] L. Pedersen,et al. The epidemiology of microscopic colitis: a 10-year pathology-based nationwide Danish cohort study , 2015, Scandinavian journal of gastroenterology.
[8] M. Vieth,et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. , 2014, Gastroenterology.
[9] J. Bohr,et al. Long‐term prognosis of clinical symptoms and health‐related quality of life in microscopic colitis: a case–control study , 2014, Alimentary pharmacology & therapeutics.
[10] A. Nicholls,et al. Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers , 2013, The Journal of international medical research.
[11] W. Sandborn,et al. Symptomatic Overlap Between Microscopic Colitis and Irritable Bowel Syndrome: A Prospective Study , 2013, Inflammatory bowel diseases.
[12] T. Smyrk,et al. Outcomes of Patients With Microscopic Colitis Treated With Corticosteroids: A Population-Based Study , 2013, The American Journal of Gastroenterology.
[13] D. Aust,et al. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. , 2012, Journal of Crohn's & colitis.
[14] L. Munck,et al. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease ‐ microscopic colitis? , 2012, Alimentary pharmacology & therapeutics.
[15] B. Jiang,et al. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China , 2012, International Journal of Colorectal Disease.
[16] L. Munck,et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups , 2011, Alimentary pharmacology & therapeutics.
[17] M. Storr,et al. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] A. Otley,et al. Budesonide in the treatment of inflammatory bowel disease , 2011, Expert review of clinical immunology.
[19] C. Andrews,et al. The association of coeliac disease and microscopic colitis: a large population‐based study , 2011, Alimentary pharmacology & therapeutics.
[20] J. Bohr,et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis , 2009, Inflammatory bowel diseases.
[21] M. Stolte,et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. , 2009, Gastroenterology.
[22] W. Sandborn,et al. T1193 A Randomized, Double-Blind, Placebo-Controlled Trial of Budesonide for the Treatment of Active Lymphocytic Colitis , 2009 .
[23] M. Stolte,et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. , 2008, Gastroenterology.
[24] L. A. Christensen,et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial , 2008, Gut.
[25] G. Kaplan,et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] A. Griffiths,et al. Budesonide for induction of remission in Crohn's disease. , 2008, The Cochrane database of systematic reviews.
[27] J. Macdonald,et al. Interventions for treating lymphocytic colitis. , 2008, The Cochrane database of systematic reviews.
[28] C. Calabrese,et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: Randomized controlled trial , 2007, Journal of gastroenterology and hepatology.
[29] M. Rudling,et al. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis , 2006, Alimentary pharmacology & therapeutics.
[30] J. Kleibeuker,et al. Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. , 2005, The Netherlands journal of medicine.
[31] J. Hansen,et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis , 2003, Gut.
[32] A. Stallmach,et al. Oral Budesonide Significantly Improves Water Absorption in Patients with Ileostomy for Crohn Disease , 2003, Scandinavian journal of gastroenterology.
[33] M. Stolte,et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. , 2002, Gastroenterology.
[34] P. Rutgeerts,et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. , 2002, Gastroenterology.